What is ZAVESCA:

ZAVESCA is a medicine that contains the active substance Miglustat and is available as Capsules.

Packing: Box of 4 blister strips, each blister strip containing 21 capsules providing a total of 84 capsules.

In how many countries ZAVESCA is approved for marketing?

ZAVESCA is available/approved in USA and Europe. We can help you to access it in India.

What is ZAVESCA used for?

ZAVESCA is indicated for the oral treatment of adult patients with mild to moderate type 1 Gaucher disease. Zavesca may be used only in the treatment of patients for whom enzyme replacement therapy is unsuitable. Zavesca is indicated for the treatment of progressive neurological manifestations in adult patients and paediatric patients with Niemann-Pick Type C disease.